RxDoctor Payments Data

Gabriela Kaldan, DO

Family Medicine · Lone Tree, CONPI 1619439189

Payments from drug & device makers

$868in general payments, 2019–2025

Across 37 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$212
  • Edwards Lifesciences$156
  • Novo Nordisk$80
  • Pfizer$69
  • Astellas Pharma US Inc$50
  • Abiomed$40
  • plus $262 from 11 others

What the payments were for

  • Food & beverage$868100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$868 in reported general payments places this provider in the 75th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$32,138
Medicare patients
80
Services billed
299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$36,196
OzempicSemaglutide29$35,916
EliquisApixaban19$16,640
FarxigaDapagliflozin Propanediol13$9,750
Gabapentin42$1,378
SynthroidLevothyroxine Sodium12$1,066
Rosuvastatin Calcium65$864
Bupropion XlBupropion Hcl16$628
Levothyroxine Sodium75$534
Olmesartan Medoxomil33$491
Duloxetine Hcl23$449
Escitalopram Oxalate18$394
Tramadol Hcl26$364
Spironolactone17$327
Atorvastatin Calcium84$326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$31$36,19634 claims
Novo NordiskOzempic$80$35,91629 claims
PfizerEliquis$69$16,64019 claims
AbbVieSynthroid$212$1,06612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Lone Tree

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →